1. Home
  2. NTWK vs RANI Comparison

NTWK vs RANI Comparison

Compare NTWK & RANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NetSol Technologies Inc.

NTWK

NetSol Technologies Inc.

HOLD

Current Price

$4.30

Market Cap

91.8M

Sector

Technology

ML Signal

HOLD

Logo Rani Therapeutics Holdings Inc.

RANI

Rani Therapeutics Holdings Inc.

SELL

Current Price

$0.57

Market Cap

84.6M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
NTWK
RANI
Founded
1997
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
91.8M
84.6M
IPO Year
1997
2021

Fundamental Metrics

Financial Performance
Metric
NTWK
RANI
Price
$4.30
$0.57
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
★ $7.20
AVG Volume (30 Days)
179.6K
★ 476.8K
Earning Date
11-12-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 57.14
EPS
★ 0.01
N/A
Revenue
★ $78,145,875.00
$1,633,000.00
Revenue This Year
$14.51
$317.02
Revenue Next Year
$9.99
N/A
P/E Ratio
$436.00
★ N/A
Revenue Growth
6.92
★ 58.85
52 Week Low
$2.80
$0.50
52 Week High
$8.46
$1.91

Technical Indicators

Market Signals
Indicator
NTWK
RANI
Relative Strength Index (RSI) 29.14 42.85
Support Level $4.20 $0.51
Resistance Level $4.65 $0.85
Average True Range (ATR) 0.63 0.04
MACD -0.42 0.01
Stochastic Oscillator 5.10 58.08

Price Performance

Historical Comparison
NTWK
RANI

About NTWK NetSol Technologies Inc.

NETSOL Technologies Inc is an information technology and enterprise software solutions provider to original equipment manufacturers (OEMs), dealerships, and financial institutions to sell, finance, and lease assets. The firm's products include Transcend Retail, Transcend Finance, Transcend Marketplace, Transcend Consultancy, and Transcend AI Labs, catering to its customers in the different stages of how assets are sold, financed, and leased. Its primary sources of revenue are licensing, subscriptions, modification, enhancement, and support of its suite of financial applications offered to businesses in the finance and leasing space, as well as automotive digital retail. The company has three reportable segments: Asia-Pacific, its key revenue-generating market, North America, and Europe.

About RANI Rani Therapeutics Holdings Inc.

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.

Share on Social Networks: